Back to search

Article

From Fragmented Evidence to a Unified GCC Demyelinating Disease Registry: A Strategic Framework for MS, NMOSD, MOGAD, Optic Neuritis, LETM, and Pediatric Acquired Demyelination

2026-08-24

Abstract excerpt

<h4>Background: </h4> Inflammatory demyelinating diseases of the central nervous system, including multiple sclerosis (MS), aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG-positive NMOSD), seronegative NMOSD, myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), recurrent optic neuritis, longitudinally extensive transverse myelitis (LETM), and pediatric acq...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eb0899af-1a66-5173-a944-952fbad8a1ba
DOI
10.20944/preprints202608.1647.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
From Fragmented Evidence to a Unified GCC Demyelinating Disease Registry: A Strategic Framework for MS, NMOSD, MOGAD, Optic Neuritis, LETM, and Pediatric Acquired DemyelinationDOI 10.20944/preprints202608.1647.v1
Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from GermanySemantic proximity
The Austrian MS Database and the Austrian MS Cohort – a national effort towards data harmonization and prospective data collectionSemantic proximity
Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.Semantic proximity
[Clinical features and modern diagnostic criteria of the disease associated with myelin oligodendrocyte glycoprotein antibody disease].Semantic proximity
Dysimmune Inflammatory Neuropathies (DINs): A Narrative Literature Review and European Patient PerspectivesSemantic proximity
Differences in clinical features, disease outcomes and imaging features of demyelinating syndrome after MOG antibody therapySemantic proximity
High dimensional mass cytometry analysis unravels distinct profiles of peripheral blood mononuclear cells in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease or in healthSemantic proximity
Etiological spectrum of non-compressive myelopathies in Uganda: a prospective, observational study using neuroimaging, autoantibodies, and next-generation sequencingSemantic proximity
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.Semantic proximity
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe FormsSemantic proximity
Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.Semantic proximity
Select a neighboring publication to make it the new centre.